Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
What upper market value could the Temporary Mechanical Circulatory Support Device Market reach by 2030 starting from 2026 levels?
The market for temporary mechanical circulatory support devices has experienced robust growth in recent years. It is anticipated to increase from $2.66 billion in 2025 to $2.9 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.0%. The expansion observed in prior periods can be attributed to several factors, including the restricted accessibility of temporary MCS devices, the prevalent use of invasive open-heart surgeries, significant mortality rates resulting from cardiogenic shock, a rising need for acute cardiac care, and the lack of portable and wearable solutions.
The temporary mechanical circulatory support device market is projected to experience robust expansion over the coming years. Its valuation is set to reach $4.1 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.0%. This anticipated growth during the forecast timeframe is largely due to innovations in biomimetic and hybrid devices, the growing preference for minimally invasive mcs, an uptick in cardiac surgery procedures, the proliferation of outpatient cardiac centers, and the incorporation of digital monitoring and intelligent hemodynamic management solutions. Key trends foreseen for the same period encompass the increasing acceptance of percutaneous ventricular assist devices, greater utilization of extracorporeal membrane oxygenation (ecmo), an increase in high-risk cardiac interventions, the broadening scope of bridge-to-transplant and bridge-to-recovery uses, and an emphasis on developing minimally invasive and portable mcs devices.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27434&type=smp
Which Drivers Are Influencing Long-Term Growth In The Temporary Mechanical Circulatory Support Device Market?
The rising prevalence of cardiovascular conditions is anticipated to drive expansion in the temporary mechanical circulatory support device market in the future. Cardiovascular diseases (CVD) encompass various ailments impacting the heart and blood vessels, resulting in issues like heart attacks, strokes, and high blood pressure. The uptick in cardiovascular diseases is attributable to an aging demographic, given that advanced age heightens the susceptibility to heart and vascular problems. These temporary mechanical circulatory support devices aid individuals suffering from cardiovascular diseases by offering transient assistance to heart function and enhancing circulation during severe states like heart failure or cardiogenic shock. An example of this trend is a report from GOV.UK, a UK-based government agency, in December 2024, stating that approximately 2.24 million adults in England, representing about 4.4% of individuals aged 18 and over, received a GP-recorded diagnosis of CKD in March 2024. This figure indicates an increase from 2.09 million cases recorded in the preceding year. Consequently, the growing occurrence of cardiovascular diseases is propelling market expansion for the temporary mechanical circulatory support device market.
Which Segments Are Driving Activity In The Temporary Mechanical Circulatory Support Device Market?
The temporary mechanical circulatory support device market covered in this report is segmented –
1) By Type: Left Ventricular Support Devices, Right Support Devices, Biventricular Support Devices
2) By Technology: Pneumatic Devices, Mechanical Pumps, Biomimetic Devices, Hybrid Systems, Novel Wearable Devices
3) By Application: Cardiogenic Shock, Bridge To Transplantation, Bridge To Recovery, High-Risk Cardiac Procedures, Other Applications
4) By End User: Hospitals, Cardiac Surgery Centers, Outpatient Surgical Facilities, Research And Academic Institutions, Other End-Users
Subsegments:
1) By Left Ventricular Support Devices: Intra-Aortic Balloon Pump, Percutaneous Ventricular Assist Device, Extracorporeal Membrane Oxygenation
2) By Right Support Devices: Right Ventricular Assist Device, Extracorporeal Membrane Oxygenation, Percutaneous Right Ventricular Assist Device
3) By Biventricular Support Devices: Biventricular Assist Device, Temporary Total Artificial Heart, Extracorporeal Membrane Oxygenation
Which Trends Are Expected To Influence The Temporary Mechanical Circulatory Support Device Market In The Upcoming Years?
Leading companies within the temporary mechanical circulatory support (tMCS) device market are establishing strategic collaborations to advance technological development. For example, in November 2025, VenstraMedical, an Australian cardiovascular medical device firm, joined forces with Highcroft Capital, a US-based venture capital company, to secure crucial investment. This funding aims to expedite the creation of VenstraMedical’s next-generation percutaneous ventricular assist device (pVAD). This compact, catheter-delivered pump is engineered to provide comprehensive ventricular unloading and hemodynamic assistance to patients suffering from cardiogenic shock or those undergoing high-risk coronary procedures. The device, protected by several patents, allows for minimally invasive insertion and can achieve up to 7 liters per minute of cardiac output. This investment underscores VenstraMedical’s goal to transform temporary mechanical circulatory support in a market valued over $2 billion, with upcoming plans for clinical trials and commercialization.
Which Key Market Players Are Investing In Expansion And Innovation Within The Temporary Mechanical Circulatory Support Device Market?
Major companies operating in the temporary mechanical circulatory support device market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Getinge AB, LivaNova PLC, Magenta Medical Ltd., CorWave SA, Procyrion Inc., CardioBridge GmbH, Abiomed Inc., Berlin Heart GmbH, Thoratec Corporation, PulseCath BV, TandemLife Inc., SynCardia Systems LLC, CardiacAssist Inc., Xenios AG, Nihon Kohden Corporation, Eurosets Srl, Senko Medical Instrument Manufacturing Co Ltd, Nipro Medical Corporation, Calon Cardio-Technology Ltd., Windmill Cardiovascular Systems Inc.
Access The Complete Report For Deeper Market Insights:
Which Regions Are Projected To Dominate The Temporary Mechanical Circulatory Support Device Market In The Coming Years?
North America was the largest region in the temporary mechanical circulatory support device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the temporary mechanical circulatory support device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Temporary Mechanical Circulatory Support Device Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27434&type=smp
Browse Through More Reports Similar to the Global Temporary Mechanical Circulatory Support Device Market 2026, By The Business Research Company
Liquid Roofing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/liquid-roofing-global-market-report
Automotive Roof System Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/automotive-roof-system-global-market-report
Roofing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/roofing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company